 | • レポートコード：D005-11169 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ニューカッスル病ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ニューカッスル病ワクチンの種類別市場規模（生ワクチン、不活化ワクチン）、用途別市場規模（鶏肉、鴨肉・ガチョウ、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）： ・地域別グローバル市場分析 2015年-2020年 ・ニューカッスル病ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ニューカッスル病ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ニューカッスル病ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ニューカッスル病ワクチンの南米市場（ブラジル、アルゼンチン） ・ニューカッスル病ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生ワクチン、不活化ワクチン ・用途別分析：鶏肉、鴨肉・ガチョウ、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Summary
Market Overview
The global Newcastle Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 348.3 million by 2025, from USD 305.3 million in 2019.
The Newcastle Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Newcastle Disease Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Newcastle Disease Vaccine market has been segmented into Live Vaccines, Killed Vaccines, etc.
By Application, Newcastle Disease Vaccine has been segmented into Chicken, Duck & Goose, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Newcastle Disease Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Newcastle Disease Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Newcastle Disease Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Newcastle Disease Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Newcastle Disease Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Newcastle Disease Vaccine Market Share Analysis
Newcastle Disease Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Newcastle Disease Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Newcastle Disease Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Newcastle Disease Vaccine are: Merial, DHN, Ringpu Biology, CEVA, Merck Animal Health, QYH Biotech, ChengDu Tecbond, Harbin Veterinary Research Institute, Yebio, Zoetis, Elanco (Lohmann), Vaksindo, FATRO, CAVAC, etc. Among other players domestic and global, Newcastle Disease Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Newcastle Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Newcastle Disease Vaccine, with price, sales, revenue and global market share of Newcastle Disease Vaccine in 2018 and 2019.
Chapter 3, the Newcastle Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Newcastle Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Newcastle Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Newcastle Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Newcastle Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Newcastle Disease Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Newcastle Disease Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Overview of Global Newcastle Disease Vaccine Market
1.4.1 Global Newcastle Disease Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merial SWOT Analysis
2.1.4 Merial Product and Services
2.1.5 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 DHN
2.2.1 DHN Details
2.2.2 DHN Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DHN SWOT Analysis
2.2.4 DHN Product and Services
2.2.5 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ringpu Biology
2.3.1 Ringpu Biology Details
2.3.2 Ringpu Biology Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ringpu Biology SWOT Analysis
2.3.4 Ringpu Biology Product and Services
2.3.5 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CEVA
2.4.1 CEVA Details
2.4.2 CEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CEVA SWOT Analysis
2.4.4 CEVA Product and Services
2.4.5 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck Animal Health
2.5.1 Merck Animal Health Details
2.5.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck Animal Health SWOT Analysis
2.5.4 Merck Animal Health Product and Services
2.5.5 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 QYH Biotech
2.6.1 QYH Biotech Details
2.6.2 QYH Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 QYH Biotech SWOT Analysis
2.6.4 QYH Biotech Product and Services
2.6.5 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 ChengDu Tecbond
2.7.1 ChengDu Tecbond Details
2.7.2 ChengDu Tecbond Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ChengDu Tecbond SWOT Analysis
2.7.4 ChengDu Tecbond Product and Services
2.7.5 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Harbin Veterinary Research Institute
2.8.1 Harbin Veterinary Research Institute Details
2.8.2 Harbin Veterinary Research Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Harbin Veterinary Research Institute SWOT Analysis
2.8.4 Harbin Veterinary Research Institute Product and Services
2.8.5 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Yebio
2.9.1 Yebio Details
2.9.2 Yebio Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Yebio SWOT Analysis
2.9.4 Yebio Product and Services
2.9.5 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Zoetis
2.10.1 Zoetis Details
2.10.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Zoetis SWOT Analysis
2.10.4 Zoetis Product and Services
2.10.5 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Elanco (Lohmann)
2.11.1 Elanco (Lohmann) Details
2.11.2 Elanco (Lohmann) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Elanco (Lohmann) SWOT Analysis
2.11.4 Elanco (Lohmann) Product and Services
2.11.5 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vaksindo
2.12.1 Vaksindo Details
2.12.2 Vaksindo Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Vaksindo SWOT Analysis
2.12.4 Vaksindo Product and Services
2.12.5 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 FATRO
2.13.1 FATRO Details
2.13.2 FATRO Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 FATRO SWOT Analysis
2.13.4 FATRO Product and Services
2.13.5 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 CAVAC
2.14.1 CAVAC Details
2.14.2 CAVAC Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 CAVAC SWOT Analysis
2.14.4 CAVAC Product and Services
2.14.5 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Newcastle Disease Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Newcastle Disease Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Newcastle Disease Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Newcastle Disease Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Newcastle Disease Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Newcastle Disease Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
6.4 France Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Newcastle Disease Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Newcastle Disease Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Newcastle Disease Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
7.5 India Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Newcastle Disease Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Newcastle Disease Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Newcastle Disease Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Newcastle Disease Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Newcastle Disease Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Newcastle Disease Vaccine Price by Type (2015-2020)
11 Global Newcastle Disease Vaccine Market Segment by Application
11.1 Global Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Newcastle Disease Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Newcastle Disease Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Newcastle Disease Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Newcastle Disease Vaccine Market Forecast (2021-2025)
12.2.2 Europe Newcastle Disease Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Newcastle Disease Vaccine Market Forecast (2021-2025)
12.2.4 South America Newcastle Disease Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Newcastle Disease Vaccine Market Forecast (2021-2025)
12.3 Newcastle Disease Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Newcastle Disease Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Newcastle Disease Vaccine Market Share Forecast by Type (2021-2025)
12.4 Newcastle Disease Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Newcastle Disease Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Newcastle Disease Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Newcastle Disease Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Newcastle Disease Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merial Basic Information, Manufacturing Base and Competitors
Table 8. Merial Newcastle Disease Vaccine Major Business
Table 9. Merial Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Merial SWOT Analysis
Table 11. Merial Newcastle Disease Vaccine Product and Services
Table 12. Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. DHN Basic Information, Manufacturing Base and Competitors
Table 14. DHN Newcastle Disease Vaccine Major Business
Table 15. DHN Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. DHN SWOT Analysis
Table 17. DHN Newcastle Disease Vaccine Product and Services
Table 18. DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 20. Ringpu Biology Newcastle Disease Vaccine Major Business
Table 21. Ringpu Biology Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Ringpu Biology SWOT Analysis
Table 23. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 24. Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. CEVA Basic Information, Manufacturing Base and Competitors
Table 26. CEVA Newcastle Disease Vaccine Major Business
Table 27. CEVA Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. CEVA SWOT Analysis
Table 29. CEVA Newcastle Disease Vaccine Product and Services
Table 30. CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 32. Merck Animal Health Newcastle Disease Vaccine Major Business
Table 33. Merck Animal Health Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Merck Animal Health SWOT Analysis
Table 35. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 36. Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. QYH Biotech Basic Information, Manufacturing Base and Competitors
Table 38. QYH Biotech Newcastle Disease Vaccine Major Business
Table 39. QYH Biotech Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. QYH Biotech SWOT Analysis
Table 41. QYH Biotech Newcastle Disease Vaccine Product and Services
Table 42. QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 44. ChengDu Tecbond Newcastle Disease Vaccine Major Business
Table 45. ChengDu Tecbond Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. ChengDu Tecbond SWOT Analysis
Table 47. ChengDu Tecbond Newcastle Disease Vaccine Product and Services
Table 48. ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 50. Harbin Veterinary Research Institute Newcastle Disease Vaccine Major Business
Table 51. Harbin Veterinary Research Institute Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Harbin Veterinary Research Institute SWOT Analysis
Table 53. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 54. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Yebio Basic Information, Manufacturing Base and Competitors
Table 56. Yebio Newcastle Disease Vaccine Major Business
Table 57. Yebio Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Yebio SWOT Analysis
Table 59. Yebio Newcastle Disease Vaccine Product and Services
Table 60. Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Newcastle Disease Vaccine Major Business
Table 63. Zoetis Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. Zoetis SWOT Analysis
Table 65. Zoetis Newcastle Disease Vaccine Product and Services
Table 66. Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Elanco (Lohmann) Basic Information, Manufacturing Base and Competitors
Table 68. Elanco (Lohmann) Newcastle Disease Vaccine Major Business
Table 69. Elanco (Lohmann) Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 70. Elanco (Lohmann) SWOT Analysis
Table 71. Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
Table 72. Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 74. Vaksindo Newcastle Disease Vaccine Major Business
Table 75. Vaksindo Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 76. Vaksindo SWOT Analysis
Table 77. Vaksindo Newcastle Disease Vaccine Product and Services
Table 78. Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. FATRO Basic Information, Manufacturing Base and Competitors
Table 80. FATRO Newcastle Disease Vaccine Major Business
Table 81. FATRO Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 82. FATRO SWOT Analysis
Table 83. FATRO Newcastle Disease Vaccine Product and Services
Table 84. FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. CAVAC Basic Information, Manufacturing Base and Competitors
Table 86. CAVAC Newcastle Disease Vaccine Major Business
Table 87. CAVAC Newcastle Disease Vaccine Total Revenue (USD Million) (2017-2018)
Table 88. CAVAC SWOT Analysis
Table 89. CAVAC Newcastle Disease Vaccine Product and Services
Table 90. CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Newcastle Disease Vaccine Sales by Manufacturer (2018-2019) (M Doses)
Table 92. Global Newcastle Disease Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Newcastle Disease Vaccine Sales by Regions (2015-2020) (M Doses)
Table 94. Global Newcastle Disease Vaccine Sales Market Share by Regions (2015-2020)
Table 95. Global Newcastle Disease Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Newcastle Disease Vaccine Sales by Countries (2015-2020) (M Doses)
Table 97. North America Newcastle Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 98. North America Newcastle Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Newcastle Disease Vaccine Revenue Market Share by Countries (2015-2020)
Table 100. Europe Newcastle Disease Vaccine Sales by Countries (2015-2020) (M Doses)
Table 101. Europe Newcastle Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 102. Europe Newcastle Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Newcastle Disease Vaccine Sales by Regions (2015-2020) (M Doses)
Table 104. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Newcastle Disease Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Newcastle Disease Vaccine Sales by Countries (2015-2020) (M Doses)
Table 107. South America Newcastle Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 108. South America Newcastle Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Newcastle Disease Vaccine Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Newcastle Disease Vaccine Sales by Countries (2015-2020) (M Doses)
Table 111. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Newcastle Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Newcastle Disease Vaccine Revenue Market Share by Countries (2015-2020)
Table 114. Global Newcastle Disease Vaccine Sales by Type (2015-2020) (M Doses)
Table 115. Global Newcastle Disease Vaccine Sales Share by Type (2015-2020)
Table 116. Global Newcastle Disease Vaccine Revenue by Type (2015-2020) (USD Million)
Table 117. Global Newcastle Disease Vaccine Revenue Share by Type (2015-2020)
Table 118. Global Newcastle Disease Vaccine Sales by Application (2015-2020) (M Doses)
Table 119. Global Newcastle Disease Vaccine Sales Share by Application (2015-2020)
Table 120. Global Newcastle Disease Vaccine Sales Forecast by Regions (2021-2025) (M Doses)
Table 121. Global Newcastle Disease Vaccine Market Share Forecast by Regions (2021-2025)
Table 122. Global Newcastle Disease Vaccine Sales Forecast by Type (2021-2025) (M Doses)
Table 123. Global Newcastle Disease Vaccine Market Share Forecast by Type (2021-2025)
Table 124. Global Newcastle Disease Vaccine Sales Forecast by Application (2021-2025)
Table 125. Global Newcastle Disease Vaccine Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. Global Sales Market Share of Newcastle Disease Vaccine by Type in 2019
Figure 3. Live Vaccines Picture
Figure 4. Killed Vaccines Picture
Figure 5. Newcastle Disease Vaccine Sales Market Share by Application in 2018
Figure 6. Chicken Picture
Figure 7. Duck & Goose Picture
Figure 8. Other Picture
Figure 9. Global Newcastle Disease Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Newcastle Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Newcastle Disease Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 35. Global Newcastle Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Newcastle Disease Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Newcastle Disease Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Newcastle Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Newcastle Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Newcastle Disease Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Newcastle Disease Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Newcastle Disease Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Newcastle Disease Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 49. Canada Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 50. Mexico Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 51. Europe Newcastle Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Newcastle Disease Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Newcastle Disease Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 55. UK Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 56. France Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 57. Russia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 58. Italy Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 59. Asia-Pacific Newcastle Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Newcastle Disease Vaccine Revenue Market Share by Regions 2019
Figure 62. China Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 63. Japan Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 64. Korea Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 65. India Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 66. Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 67. South America Newcastle Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Newcastle Disease Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Newcastle Disease Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 71. Argentina Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 72. Middle East and Africa Newcastle Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 77. Egypt Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 78. Turkey Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 79. South Africa Newcastle Disease Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 80. Global Newcastle Disease Vaccine Sales and Growth Rate (2021-2025) (M Doses)
Figure 81. Global Newcastle Disease Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Newcastle Disease Vaccine Market Forecast (2021-2025) (M Doses)
Figure 83. Europe Sales Newcastle Disease Vaccine Market Forecast (2021-2025) (M Doses)
Figure 84. Asia-Pacific Sales Newcastle Disease Vaccine Market Forecast (2021-2025) (M Doses)
Figure 85. South America Sales Newcastle Disease Vaccine Market Forecast (2021-2025) (M Doses)
Figure 86. Middle East & Africa Sales Newcastle Disease Vaccine Market Forecast (2021-2025) (M Doses)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…- 口蹄疫（FMD）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Foot and Mouth Disease (FMD) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1280.5 million by 2025, from USD 900.9 million in 2019. The …
- 病気管理＆予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Disease Control and Prevention Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 55270 million by 2025, from USD 42850 million in 2019. The…
- mRNAワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global mRNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The mRNA Vaccine market report provi…
- 弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Live Attenuated Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Live Attenuated Vacci…